Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...

Does the pharmaceutical industry have adequate access to contained equipment, facilities, and infrastructure for the manufacture of highly potent APIs? The pharmaceutical industry has been ...

Jersey City, New Jersey, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Verified Market Research® recently published a report, “High Potency APIs/HPAPI Market” By Therapeutic Application (Oncology, Hormonal ...

Pompey, France, July 19, 2012 - Novasep, a leading supplier of manufacturing solutions to the life sciences industries, today announces a EUR three million investment to expand its Highly Potent API ...

New York, May 31, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "High Potency APIs Market/HPAPI Market by Type, Type of Synthesis, Manufacturers, Application Region - ...

Best-in-class facility enhances capacity to scale production of highly potent ingredients for customers demanding small to full GMP batches Minakem, the CDMO division of Minafin, specialized in custom ...

DUBLIN--(BUSINESS WIRE)--The "High Potency APIs/HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins ...

Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms. Highly potent compounds present numerous challenges with respect to process development, ...

ST. LOUIS, Oct 26, 2011 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), has completed an ...

Minakem, a CDMO subsidiary of Minafin, is in final qualifications to open its new closed-controlled environment high-containment production facility located in Belgium by late summer. The new facility ...